| Drug Name / Category | Drug Name / Category | Company | Genotype / (Verified) |
|---|---|---|---|
| Drug Name / Category | Drug Name / Category | Company | Genotype / (Verified) |
| Daklinza (Daclatasvir) (BMS-790052) (NS5A Inhibitor) | Sunpreva (Asunaprevir) (Protease Inhibitor) Beclabuvir (BMS-791325) (Polymerase Inhibitor) | BMS | Genotype 1 (August 31, 2015) |
| Grazoprevir (MK-5172) (Protease Inhibitor) | Elbasvir (MK-8742) (NS5A Inhibitor) | Merck | Genotype 1,2,3,4,6 (August 31, 2015) |
| Sovaldi (Sofosbuvir) (Polymerase Inhibitor) | GS-5816 (Protease Inhibitor) | Gilead | Genotype 1,2,3,4,5,6 (August 31, 2015) |
Saturday, September 12, 2015
Quick Reference Guide Phase III Clinical Trials
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.